Reports for AA PHARMA INC
Company Name
AA PHARMA INC
Totals |
||
Shortage reports |
364 |
|
Actual shortage: | 21 (6%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 6 (2%) | |
Resolved: | 337 (93%) | |
Discontinuation Reports |
58 |
|
To be discontinued: | 1 (2%) | |
Discontinued: | 55 (95%) | |
Reversed: | 2 (3%) | |
Late reports |
27 (6%) |
|
Overdue reports |
12 (55%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PEN-VK | 300MG | TABLET | Resolved | 2022-07-22 | 2022-10-22 | 165352 |
PEN-VK | 300MG | TABLET | Resolved | 2022-11-22 | 2022-12-03 | 175449 |
PEN-VK | 300MG | TABLET | Resolved | 2023-02-28 | 2023-05-13 | 185687 |
PEN-VK | 300MG | TABLET | Resolved | 2023-02-28 | 2023-05-13 | 185690 |
LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-07 | 2024-01-20 | 212786 |
LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-11 | 2024-04-02 | 221857 |
AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN | 30MG 500MG 500MG | CAPSULE (DELAYED RELEASE) KIT CAPSULE TABLET | Resolved | 2020-10-01 | 2021-06-21 | 125395 |
AA-DILTIAZ | 30MG | TABLET | Resolved | 2017-07-11 | 2018-09-28 | 15252 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-10-29 | 2021-11-19 | 148545 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156999 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-10-14 | 2023-01-06 | 171833 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-12-02 | 2022-12-23 | 176948 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-12-13 | 2024-02-22 | 213143 |
AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-04-04 | 2024-05-08 | 224320 |
SULFATRIM | 400MG 80MG | TABLET | Resolved | 2017-11-01 | 2018-03-15 | 27741 |
SULFATRIM | 400MG 80MG | TABLET | Resolved | 2018-03-29 | 2018-06-04 | 44197 |
SULFATRIM | 400MG 80MG | TABLET | Resolved | 2018-08-09 | 2018-08-29 | 57823 |
SULFATRIM | 400MG 80MG | TABLET | Resolved | 2018-12-12 | 2018-12-21 | 69321 |
PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-04-29 | 2022-07-23 | 159738 |
CIMETIDINE | 400MG | TABLET | Actual shortage | 2017-03-10 | 2017-10-05 | 99 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TETRACYCLINE | 250MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65441 |
TICLOPIDINE | 250MG | TABLET | Discontinued | 2019-04-01 | 2019-04-02 | 80166 |
DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
ERYTHRO-S | 250MG | TABLET | Discontinued | 2020-07-28 | 2020-07-29 | 121300 |
PONSTAN | 250MG | CAPSULE | Discontinued | 2020-07-28 | 2020-07-29 | 121303 |
ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2022-04-01 | 2022-04-02 | 157808 |
AA-ATENIDONE | 25MG 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4698 |
AA-ATENIDONE | 25MG 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4702 |
TRIMIPRAMINE | 25MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4528 |
AVENTYL | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65435 |
DOXEPIN | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2018-10-24 | 65458 |
DIAZEPAM | 2MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60411 |
TRIHEXYPHENIDYL | 2MG | TABLET | Reversed | 2018-12-20 | 2019-07-22 | 70209 |
ORCIPRENALINE | 2MG | SYRUP | Discontinued | 2020-03-10 | 2020-03-11 | 108373 |
ORAP | 2MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121834 |
ETODOLAC | 300MG | CAPSULE | Discontinued | 2018-12-20 | 2019-01-14 | 70191 |
CIMETIDINE | 300MG | TABLET | To be discontinued | 2019-01-02 | 2019-01-02 | 70796 |
AA-DILTIAZ | 30MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60429 |
SULFATRIM | 400MG 80MG | TABLET | Discontinued | 2018-09-10 | 2018-11-09 | 61036 |
PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |